Severe Childhood COVID-19 Associated With Heightened Cardiovascular Risk in Adulthood
The development of multisystem inflammatory syndrome in children infected with SARS-CoV-2 was associated with more marked shifts in metabolic parameters,…
Setting and Implementing Standards for Narrow Therapeutic Index Drugs
CDER’s Narrow Therapeutic Index Drugs (NTI) working group works to resolve key NTI scientific and regulatory issues.
MET Inhibitor With Chemoimmunotherapy Overcomes Treatment Resistance in Some Patients With SCLC
Both preclinical and translational evidence support MET inhibition as a therapeutic approach in patients with small cel lung cancer (SCLC).
CVS Caremark fined $290M for Medicare fraud
CVS tried and failed to convince the judge to decrease the penalty. The company plans to appeal the ruling.
FaceTec Introduces a Whole New Dimension into Authentication and Security
FaceTec is so confident in its face verification technology that it launched a Spoof Bounty Program to challenge anyone to…
Advancing Generic Drug Development: Translating Science to Approval 2025 – 10/07/2025
Join us for the 2025 Advancing Generic Drug Development Workshop! FDA experts will demonstrate the FDA’s Generic Drug User Fee…
Antibody-Drug Conjugates Poised to Revolutionize Treatment of Urothelial Carcinoma
Enfortumab vedotin is one of many effective antibody-drug conjugates on the market that can be utilized to improve the treatment…
Medicare Advantage headwinds dinging member satisfaction: survey
Overall customer satisfaction with MA plans fell 29 points year over year, driven by a declining level of member trust…
Comparative Real-World Effectiveness of Rituximab vs Cladribine in Relapsing-Remitting Multiple Sclerosis
Study reveals rituximab outperforms cladribine in managing RRMS, showing superior disease control and improved disability outcomes.
How Nurses Can Build and Sustain Trust in Healthcare AI
The following is a guest article by Ali Morin, MSN, RN, NI-BC, Chief Nursing Informatics Officer at symplr When I…